Clinical Trials Directory

Trials / Completed

CompletedNCT03105921

Irreversible Electroporation (NanoKnife) for the Treatment of Pancreatic Adenocarcinoma

Intérêt de l'électroporation irréversible Dans le Traitement de l'adénocarcinome du pancréas

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Poitiers University Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to evaluate the use of irreversible electroporation in the treatment of locally advanced cancers of the head of pancreas with vascular spread. This technique would allow to treat the unresectable part of the tumor to make it more accessible for a secondary surgery.

Conditions

Interventions

TypeNameDescription
DEVICENanoKnifeThe aim of the treatment is to sourround the tumour with two to six needles and to deliver a very high voltage current (3000 volts in 70 to 80 microseconds pulses) by a generator synchronized with an electrocardiogram.

Timeline

Start date
2014-10-24
Primary completion
2021-04-01
Completion
2021-04-01
First posted
2017-04-10
Last updated
2022-03-31

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03105921. Inclusion in this directory is not an endorsement.